Currently diabetic patients wear sensors that track and communicate their glucose levels, as well as alarm when they go out of range. The patient, if aware and shrewd, then injects the correct amount of insulin based on the glycemic level and carbohydrate counting. It is evident that a solution in which the sensor is directly connected with the insulin pump, when controlled by an appropriate algorithm, would have a significant impact on the patient’s safety and quality of life.
This invention relates to the method of controlling the insulin delivery in diabetic patients. More specifically, the method relates to coordination of the insulin pump activity with information received from a wearable sensor. It is achieved through the combination of two control methods. The first one relies on a standard method that correlates the quantities of food consumed to the actions to be taken as determined by the diabetologist, while the second one uses the predictive model and is designed to react to changes in blood glucose levels with the objective to keep the glycemia in the range of 70-140 mg/dl.

TRL (Technology Readiness Level)

TRL 6/7 / 9








Download the brochure

  • Estimation of insulin sensitivity from CGM and subcutaneous insulin delivery in type 1 diabetes

    In the last 15-20 years new tools in diabetes therapy have emerged such as Continuous Glucose Monitoring (CGM) and Continuous Subcutaneous Insulin Infusion (CSII) which are destined to substitute Self Monitored Blood Glucose (SMBG) and Multiple Daily Injection (MDI) technologies[...]

  • Device for visualization of the anus during standard colonoscopy

    Colonoscopy with a flexible endoscope is a fundamental exam for cancer screening, it allows early diagnosis of colon and rectal cancers. Over 16.6 million colonoscopies are performed annually in United States. In the prior art, during colonoscopy the visualization of[...]

  • Glioblastoma multiforme: a new prognostic index of survival

    Glioblastoma (GBM) is the most common brain cancer among adults and patients and has an overall survival (OS) of 15 months. Nowadays brain tumours are not taken in evaluation in relation to the brain area in which they are located.[...]

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation